Growth of European Blood Culture Testing Industry Shifts into High Gear with Technological Advancements in Medical Sector

Published Date : Jun 14, 2016

ALBANY, NY, June 14, 2016: A new market research study has recently been added by to its huge database of research reports. The study offers a detailed reports of the blood culture testing industry in Europe, focusing on the key growth drivers, barriers, product segmentation, and competitive landscape. The 138-page research study, titled “European Blood Culture Testing Industry 2016 Market Research Report,” discusses the current trends and major opportunities in the European blood culture testing industry. The research study offers a comprehensive overview, comprising the definitions, applications, classifications, and the structure of the blood culture testing industry in Europe.

A blood culture is a test carried out to determine if there is any infection in the blood. The presence of bacteria or fungi in the blood may be an indication of an infection, which may weaken the immune system of a person if not addressed. Some of the latest technologies that are being used for blood culture tests are the use of the molecular technique, mass spectrometry, multiplex real-time PCR system, and electro spray ionization.

The growing prevalence of diseases is one of the major factors driving the blood culture testing industry in Europe. The research study has presented the past performance of the European blood culture testing industry along with the future projections with the help of tables, charts, and infographics. Furthermore, the feasibility of novel investment projects is evaluated and research conclusions are presented. 

The rising incidence of several blood stream infections and the growing demand for diagnostic tests are the key factors projected to bolster the growth of the European blood culture testing industry throughout the forecast period. In addition, the technological advancements in the medical sector and the rising awareness among the population regarding the availability of latest technologies are anticipated to propel the European blood culture testing industry in the next few years.

For Sample Copy, click here:

On the flip side, the lack of appropriate reimbursement policies and the high cost of the advanced techniques used for blood culture are anticipated to curb the growth of the blood culture testing industry in Europe. Nevertheless, the identification of antibiotic-resistant microorganisms holds potential opportunities for growth of the major players operating in the blood culture testing industry in Europe.

The prominent players operating in the blood culture testing industry in Europe include Becton, Dickinson and Company, Abbott, Siemens, Biomerieux, Alere, F. Hoffmann-La Roche Ltd., Bruker Corporation, Thermo Fisher, Nanosphere, and Cepheid.

Detailed profiles of the leading companies have been studied in the research study, focusing on their financial overview, product specification, business policies, production, cost, capacity, gross, price, and revenue. The SWOT reports of the major companies has also been provided in the scope of the research report to offer a clear understanding of the industry. 

To order report Call Toll Free: 866-997-4948 or send an email on